Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...

Vertex stock nose-dived Tuesday after the biotech company said it wouldn't advance its next-generation pain drug into ...

What Happened? Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) fell 17.4% in the afternoon session after the ...

In connection with earnings, Vertex announced topline results from the Phase 2 study evaluating the safety and efficacy of VX ...

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit ...

Vertex Pharmaceuticals (VRTX) posts strong Q2 earnings and revenue growth but faces a 17% stock drop after mid-stage pain drug failure. Read more here.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $481.56, ...

Graph partitioning is crucial in distributed graph-parallel computing systems, and it is challenging for graph partitioning to optimize the communication cost and load balancing together. Existing ...

The selection of routing in a network has a direct impact on the effectiveness of the communication system. Good routing selection will not cause blockage or collapse of the communication network due ...